Statements (71)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:High_School
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:GSK
|
| gptkbp:acquired |
gptkb:Novartis_AG
|
| gptkbp:aims_to |
improve public health
|
| gptkbp:collaborated_with |
non-profit organizations
international health organizations |
| gptkbp:collaborates_with |
research institutions
|
| gptkbp:dedicated_to |
patient safety
immunization awareness |
| gptkbp:develops |
gptkb:drug
immunization programs therapeutic vaccines adjuvanted vaccines |
| gptkbp:employs |
gptkb:physicist
|
| gptkbp:established |
partnerships with universities
global distribution networks |
| gptkbp:focuses_on |
vaccine development
preventive medicine global vaccination efforts vaccine research and development vaccine innovation vaccine accessibility vaccine affordability |
| gptkbp:founded |
gptkb:1996
|
| gptkbp:has_achievements |
multiple vaccine approvals
|
| gptkbp:has_impact_on |
global health
|
| gptkbp:has_part |
manufacturing facilities
vaccine research division |
| gptkbp:has_product |
vaccines
|
| gptkbp:headquartered_in |
gptkb:Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Novartis vaccines business
|
| gptkbp:investment |
gptkb:Company
|
| gptkbp:is_active_in |
emerging markets
|
| gptkbp:is_committed_to |
sustainability
|
| gptkbp:is_engaged_in |
community outreach programs
vaccine education healthcare partnerships vaccine education programs |
| gptkbp:is_involved_in |
clinical trials
public health campaigns vaccine research funding vaccine supply chain management vaccine safety monitoring vaccine policy advocacy vaccine distribution logistics vaccine distribution strategies vaccine research collaborations vaccine effectiveness studies vaccine research ethics vaccine technology advancements |
| gptkbp:is_known_for |
high-quality production
|
| gptkbp:is_part_of |
global health initiatives
biopharmaceutical sector global health strategies Novartis portfolio |
| gptkbp:is_recognized_for |
commitment to research
leadership in vaccine development innovation in vaccines |
| gptkbp:is_subject_to |
regulatory approvals
|
| gptkbp:is_supported_by |
gptkb:Research_Institute
|
| gptkbp:offers |
consultation services
|
| gptkbp:operates_in |
gptkb:Company
|
| gptkbp:part_of |
gptkb:Novartis
|
| gptkbp:participates_in |
healthcare initiatives
|
| gptkbp:partnership |
government agencies
|
| gptkbp:produced_by |
vaccines for children
vaccines for adults |
| gptkbp:received |
awards for excellence
|
| gptkbp:research |
vaccine efficacy
|
| gptkbp:targets |
infectious diseases
|